Search Results

Displaying Results 176-200 of 17444 "'NOV'"

Jul 13, 2026, 14:28 ET Annual Wine, Dine & Jazz Festival Returns to Horseshoe Bay Resort Nov. 6-7, 2026

21st Annual Wine, Dine & Jazz Festival, returning Nov. 6–7, 2026. A hallmark fall tradition in the Texas Hill Country, the festival brings together top culinary talent, acclaimed musicians and wine enthusiasts

More news about: Horseshoe Bay Resort


Jul 13, 2026, 07:00 ET Olive Garden Announces the Return of its Iconic Never-Ending Pasta Pass

Bowl starting Aug. 24, and the promotion officially begins Aug. 31 to Nov. 22. Never-Ending Pasta Bowl Never-Ending Pasta Bowl, Olive Garden's fan-favorite promotion, will return nationwide from Aug. 31 to Nov. 22, starting at $14.99, and allowing guests to craft their perfect

More news about: Olive Garden


Jul 09, 2026, 14:15 ET Nevada Partnership for Homeless Youth and Las Vegas Sands Announce the 2026 Nevada Youth Homelessness Summit is Scheduled for Nov. 13

-- Nevada Partnership for Homeless Youth (NPHY) and Las Vegas Sands (NYSE: LVS) will co-present the 2026 Nevada Youth Homelessness Summit on Friday, Nov. 13, at the Historic Fifth Street School in Downtown Las Vegas. Registration for the state's premier youth homelessness advocacy event opens July 14

More news about: Las Vegas Sands Corp.


Jul 09, 2026, 11:00 ET BACKSTREET BOYS TO HEADLINE OFFICIAL F1® AFTERPARTY AT SPHERE DURING FORMULA 1 HEINEKEN LAS VEGAS GRAND PRIX 2026, NOVEMBER 21

Official Post-Race Show of the FORMULA 1 HEINEKEN LAS VEGAS GRAND PRIX, featuring a special performance by the Backstreet Boys on Saturday, Nov. 21 at Sphere, where advanced technology is redefining the future of live entertainment. Click

More news about: FORMULA 1 HEINEKEN LAS VEGAS GRAND PRIX


Jul 09, 2026, 09:00 ET EMBC INVESTOR DEADLINE: Embecta Corp. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit-- HBSS

submit your losses now.Class Period: Nov. 25, 2025 – May 4, 2026Lead Plaintiff Deadline: Aug. 17, 2026Visit:

More news about: Hagens Berman Sobol Shapiro LLP


Jul 09, 2026, 09:00 ET SRAD Investor Notice: Sportradar Group AG Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit- HBSS

youtu.be/90cf7_368dkClass Period: Nov. 7, 2024 – Apr. 21, 2026Lead Plaintiff Deadline: July 17, 2026Visit:

More news about: Hagens Berman Sobol Shapiro LLP


Jul 08, 2026, 09:12 ET ICAHN Highlights Rural Hospitals Providing Labor & Delivery Services While Emphasizing Emergency Obstetric Readiness Across Illinois

Precipitous Breech Delivery in the Emergency Department & Neonatal Assessment and Stabilization Simulation, while the fourth and final training, Nov. 17-18, will cover Pregnant Trauma Patient Simulation: Maternal and Fetal Assessment and Care.Each simulation was intentionally selected

More news about: Illinois Critical Access Hospital Network


Jul 07, 2026, 20:49 ET Embecta Corp. (EMBC) Faces Securities Class Action Over Alleged Concealed Material Risks to Pen Needle Revenue- HBSS

submit your losses now.Class Period: Nov. 25, 2025 – May 4, 2026Lead Plaintiff Deadline: Aug. 17, 2026Visit:

More news about: Hagens Berman Sobol Shapiro LLP


Jul 07, 2026, 20:46 ET SRAD 10-DAY DEADLINE ALERT: HBSS Investigates Sportradar Group AG (SRAD) Securities Class Action Claims After Short Seller Reports Expose Alleged Illegal Gambling Ties

youtu.be/90cf7_368dkClass Period: Nov. 7, 2024 – Apr. 21, 2026Lead Plaintiff Deadline: July 17, 2026Visit:

More news about: Hagens Berman Sobol Shapiro LLP


Jul 07, 2026, 08:00 ET Bollinger Shipyards Supports Junior Enlisted Participation in the 2026 CGMA Open

Bollinger's help further expand access and participation opportunities. The announcement comes as registration continues for the 2026 CGMA Open, scheduled for Nov. 10-12, 2026, at

More news about: Coast Guard Mutual Assistance


Jul 06, 2026, 06:00 ET Holland America Line Announces 2027-2028 Caribbean Season with Options from Quick Escapes to Extended Journeys

roundtrip from Fort Lauderdale or MiamiCalls at Nassau; RelaxAway, Half Moon Cay; Grand Turk; Amber CoveDeparts Nov. 27 (Miami), Dec. 11, 2027; Jan. 15, Jan. 29, Feb. 12, Feb. 26, March 11, March 25, 2028Holiday departure Dec. 23, 2027 (Zuiderdam)7-Day

More news about: Holland America Line


Jul 02, 2026, 09:00 ET EMBC INVESTOR DEADLINE: Embecta Corp. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit-- HBSS

submit your losses now.Class Period: Nov. 25, 2025 – May 4, 2026Lead Plaintiff Deadline: Aug. 17, 2026Visit:

More news about: Hagens Berman Sobol Shapiro LLP


Jul 02, 2026, 09:00 ET SRAD Investor Notice: Sportradar Group AG Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit- HBSS

youtu.be/90cf7_368dkClass Period: Nov. 7, 2024 – Apr. 21, 2026Lead Plaintiff Deadline: July 17, 2026Visit:

More news about: Hagens Berman Sobol Shapiro LLP


Jul 01, 2026, 22:00 ET 越來越多年輕人受落髮困擾:REGAINE®*落建引領毛髮科學研究發展

Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021 Nov 6;20(12):3759–3781. doi: 10.1111/jocd.14537. PMCID: PMC9298335 PMID: 34741573 

More news about: REGAINE®


Jul 01, 2026, 22:00 ET 越來越多年輕人受脫髮困擾:REGAINE®*培健引領毛髮科學研究發展

Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021 Nov 6;20(12):3759–3781. doi: 10.1111/jocd.14537. PMCID: PMC9298335 PMID: 34741573 

More news about: REGAINE®


Jul 01, 2026, 09:24 ET Hansa Biopharma announces closing of €115 million licensing transaction with SERB Pharmaceuticals for Idefirix in Europe and MENA

pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients. Am J Transplant. 2018 Nov;18(11):2752-2762. doi: 10.1111/ajt.14733.NIH (2018). What is kidney failure? Available at:

More news about: Hansa Biopharma AB


Jul 01, 2026, 09:15 ET Hansa Biopharma announces closing of €115 million licensing transaction with SERB Pharmaceuticals for Idefirix in Europe and MENA

pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients. Am J Transplant. 2018 Nov;18(11):2752-2762. doi: 10.1111/ajt.14733.NIH (2018). What is kidney failure? Available at:

More news about: Hansa Biopharma AB


Jun 30, 2026, 08:00 ET Basware Establishes Governed Autonomy Framework for Finance

AI from an interesting capability into something finance can actually use," said Tehreem Bokhari, VP of Finance Transformation at NOV.  A Structured Path from AI Assistance to AI Execution  Basware's Governed Autonomy Framework defines three levels of AI authority,

More news about: Basware


Jun 29, 2026, 15:29 ET HBSS Investigates Sportradar Group AG (SRAD) Securities Class Action Claims After Short Seller Reports Expose Alleged Illegal Gambling Ties

youtu.be/90cf7_368dkClass Period: Nov. 7, 2024 – Apr. 21, 2026Lead Plaintiff Deadline: July 17, 2026Visit:

More news about: Hagens Berman Sobol Shapiro LLP


Jun 29, 2026, 15:26 ET Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business -- HBSS

submit your losses now.Class Period: Nov. 25, 2025 – May 4, 2026Lead Plaintiff Deadline: Aug. 17, 2026Visit:

More news about: Hagens Berman Sobol Shapiro LLP


Jun 29, 2026, 11:00 ET USPS Announces Additional Stamps and Release Locations for 2026

annual autumn festival celebrates the triumph of good over evil. Diwali is usually observed over five days; in 2026, the main day of the festival will be Nov. 8. This second Diwali stamp issued by USPS features a rangoli, a vibrant floor pattern traditionally made from materials such as colored rice powder,

More news about: U.S. Postal Service


Jun 26, 2026, 12:35 ET Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial. Lancet. 2025 Nov 22;406(10518):2435-2448.10 IMAAVY® U.S. Prescribing Information. Available at:

More news about: Johnson & Johnson


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.